The ESC Handbook on Cardiovascular Pharmacotherapy

This European Society of Cardiology (ESC) Handbook on Cardiovascular Pharmacotherapy has been developed by experts from the ESC Working Group on Cardiovascular Pharmacotherapy. Its recommendations are aligned with the ESC Clinical Practice Guidelines and based on the most recent scientific evidence in cardiovascular pharmacology and pharmacotherapy. The Handbook provides up-to-date information on pharmacotherapy for cardiovascular disease prevention, and treatment of cardiovascular disease, including ischaemic heart disease, heart failure, arrhythmias, and structural heart disease. The Handbook also deals with the important problems of cardiovascular pharmacotherapy in pregnancy and lactation, kidney insufficiency, and liver disease as well as focusing on major drug interactions, a topic of extreme importance in clinical practice. Two large sections of the book provide a comprehensive A-Z formulary of cardiac and non-cardiac pharmacological agents with practical and accessible information on the most important pharmacological aspects of these agents and their use in clinical practice.

The Handbook represents essential reading for cardiologists, general practitioners, internal medicine specialists, anaesthetists, clinical pharmacologists, geriatricians, obstetricians, and cardiovascular nurse consultants. Junior doctors and trainees in all these specialties are also likely to find this book of help.

The print edition comes with full access to the online version that will be updated at yearly intervals to keep it up to date.

Juan Carlos Kaski, Cardiovascular Sciences Research Centre, St George's University of London, UK,Keld Per Kjeldsen, Department of Medicine (Division of Cardiology), Copenhagen University Hospital (Holbaek Hospital), Holbaek and Department of Health Science and Technology, The Faculty of Medicine, Aalborg University, Aalborg, Denmark

Professor Kaski is the Immediate Past Director of the Cardiovascular and Cell Sciences Research Institute, St George's, University of London. He is Doctor of Science, University of London, Fellow of the Royal College of physicians (London), the European Society of Cardiology, the American College of Cardiology and the American Heart Association, among over 20 other scientific societies worldwide. He is Deputy Editor in Chief, International Journal of Cardiology, Editor in Chief, European Cardiology Review and the Cardiovascular Pharmacotherapy book series, ISCP.

Professor Kjeldsen is author of over 200 papers and multiple books. Presenter of over 100 lectures nationally and internationally, he is Chairman at 45 scientific sessions. He has extensive experience as peer reviewer at scientific journals, from editorial boards, as chairman and organizer of meetings and congresses and as examiner of theses and research projects nationally and internationally. Teaching interests include Cardiology, cardiovascular pharmacology, and research methodology.

Section 1: Cardiovascular Disease Prevention SE: Heinz Drexel, Massimo Piepoli and Josep Perk
1. Hypertension, Robert Zweiker and Sabine Perl
2. Dyslipidaemia, Heinz Drexel
3. Metabolic Syndrome and Diabetes, Christoph Saly
4. Thrombosis, Freek Verheugt
Section 2: Ischaemic Heart Disease SE: Sven Wassmann and Alexander Niessner
1. Acute Coronary Syndromes, Abhiram Prasad and Claire Raphael
2. Chronic stable angina, Gaetano Antonio Lanza and Antonio De Vita
3. Coronary artery spasm and microvascular angina, Peter Ong and Udo Sechtem
4. Takotsubo Syndrome, Alexander Lyon, Mark Sweeney, and Elmir Omerovic
Section 3: Heart Failure SE: Faiez Zannad and Theresa McDonagh
1. Heart failure, Faiez Zannad, Joao Pedro Ferreira, and Theresa McDonagh
2. Heart transplantation, Finn Gustafsson and Kasper Rossing
Section 4: Arrhythmias SE: Antoni Martinez-Rubio and Dan Atar
1. Atrial fibrillation, George Dan and Jan Steffel
2. Supraventricular (narrow complex) tachycardias, Julio Marti
3. Ventricular arrhythmias, Martin Borggrefe, Erol Tulumen, and Josep Brugada
4. Bradyarrhythmias, Haran Burri
5. Syncope, Ricardo Ruiz-Granell
Section 5: Structural heart disease SE: Claudio Ceconi and Francesca Mantovani
1. Valvular Heart Disease, Francesca Mantovani
2. Myocarditis/ Pericardial Syndromes, Giovanni Boffa and Claudio Ceconi
3. Cardiomyopathy, Giovanni Boffa
4. Pulmonary Hypertension, James Tonkin, Kate Ryan and Brendan Madden
Section 6: Management of cardiovascular disease in pregnancy and lactation and in the presence of co-morbidities SE: Debasish Banerjee and David Goldsmith
1. Kidney disease, Debasish Banerjee, Robin Ramphul, and David Goldsmith
2. Pregnancy and lactation, Anita Banerjee, Debasish Banerjee, and Vivek Jha
3. Liver disease, Nina Hojs, Aftab Ala, and Debasish Banerjee
Section 7: Major drug interactions SE: Birgitte Klindt Poulsen and Ljubica Vukelic Andersen
1. Major drug interactions, Maja Hellfritzsch Poulsen and Marlene Lunddal Krogh
Section 8: Cardiovascular drugs from A to Z SE: Juan Tamargo
1. Cardiovascular drugs from A to Z, Juan Tamargo, Ricardo Caballero and Eva Delpon
Section 9: Non-cardiac drugs affecting the heart - from A to Z SE: Juan Tamargo
1. Non-cardiac drugs affecting the heart, Eva Delpon and Juan Tamargo